Keerthi Indus (518011)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Profit growth of 44.54% suggests the loss may be narrowing compared to the prior period.
• Piotroski F-Score of 5/9 shows at least some fundamental improvement signals, not an outright distress score.
• Price at ₹111.70 is at the 52-week high, indicating strong market expectations of a recovery.
• Book value of ₹65.08 per share provides a baseline asset anchor, assuming asset quality is reasonable.

Concerns

• Latest quarter net loss of ₹6 crore on sales of ₹16 crore implies a net margin of roughly -37.5%.
• ROE of -32.67% and ROCE of -24.53% show severe erosion of shareholder capital.
• Sales growth of -36.03% means the top line is shrinking rapidly.
• P/B of 1.72 with negative returns means investors are paying a premium for an unprofitable business.
• No dividend, no disclosed promoter holding, and no debt/equity data reduce transparency and income support.

AI Analysis

I always ask three questions: Is the business understandable, does it earn good returns on capital, and is the price sensible? Keerthi Indus is understandable as a cement products player, but the returns are terrible. In the latest quarter it did sales of ₹16 crore and lost ₹6 crore — a net margin of almost minus 38%. The full picture is worse: ROE is -32.67%, ROCE is -24.53%, and sales have fallen over 36%. This is not a business compounding wealth; it is consuming it. The 44.54% profit growth looks attractive at first glance, but profit growth on a loss-making base is a small consolation; the latest quarter still shows red ink. Book value is ₹65.08, but the stock trades at ₹111.70, nearly 1.7 times book. Graham would never pay a premium for a business that earns such negative returns on its assets. The P/E is zero or meaningless because there are no earnings. Patient income investors get no dividend. The Piotroski F-Score of 5 out of 9 suggests some improvement signals, and the price is at its 52-week high, so the market is betting on a turnaround. But I prefer facts over hope. Debt/equity is not available, and promoter holding is also not disclosed, so I cannot check how much leverage or skin-in-the-game exists. If the operations genuinely recover, I want to see rising sales, shrinking losses, and proof that management can earn a respectable ROCE. Until then, this is a speculative asset, not an investment. I would keep it on a watch list, not in a value portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer